10.30 (0.64%) Sun Pharmaceutical Industries has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 29, 2022 for Shanghvi Finance.
The above information is a part of company’s filings submitted to BSE.